These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15621996)

  • 1. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice.
    Steinmetz EF; Buckley C; Shames ML; Ennis TL; Vanvickle-Chavez SJ; Mao D; Goeddel LA; Hawkins CJ; Thompson RW
    Ann Surg; 2005 Jan; 241(1):92-101. PubMed ID: 15621996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).
    Moore G; Liao S; Curci JA; Starcher BC; Martin RL; Hendricks RT; Chen JJ; Thompson RW
    J Vasc Surg; 1999 Mar; 29(3):522-32. PubMed ID: 10069917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB.
    Parodi FE; Mao D; Ennis TL; Bartoli MA; Thompson RW
    J Vasc Surg; 2005 Mar; 41(3):479-89. PubMed ID: 15838484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms.
    Parodi FE; Mao D; Ennis TL; Pagano MB; Thompson RW
    Ann Vasc Surg; 2006 May; 20(3):360-8. PubMed ID: 16779518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.
    Liao S; Miralles M; Kelley BJ; Curci JA; Borhani M; Thompson RW
    J Vasc Surg; 2001 May; 33(5):1057-64. PubMed ID: 11331849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation.
    Bergoeing MP; Arif B; Hackmann AE; Ennis TL; Thompson RW; Curci JA
    J Vasc Surg; 2007 Jun; 45(6):1217-1227. PubMed ID: 17398058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.
    Mastoraki ST; Toumpoulis IK; Anagnostopoulos CE; Tiniakos D; Papalois A; Chamogeorgakis TP; Angouras DC; Rokkas CK
    Ann Vasc Surg; 2012 Feb; 26(2):250-8. PubMed ID: 22222170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin suppresses experimental aortic aneurysm expansion.
    Kalyanasundaram A; Elmore JR; Manazer JR; Golden A; Franklin DP; Galt SW; Zakhary EM; Carey DJ
    J Vasc Surg; 2006 Jan; 43(1):117-24. PubMed ID: 16414398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms.
    Annabi B; Shédid D; Ghosn P; Kenigsberg RL; Desrosiers RR; Bojanowski MW; Beaulieu E; Nassif E; Moumdjian R; Béliveau R
    J Vasc Surg; 2002 Mar; 35(3):539-46. PubMed ID: 11877705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of novel limited-spectrum MMP inhibitor XL784 in abdominal aortic aneurysms.
    Ennis T; Jin J; Bartlett S; Arif B; Grapperhaus K; Curci JA
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):417-26. PubMed ID: 22894883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No Effect of Hypercholesterolemia on Elastase-Induced Experimental Abdominal Aortic Aneurysm Progression.
    Ikezoe T; Shoji T; Guo J; Shen F; Lu HS; Daugherty A; Nunokawa M; Kubota H; Miyata M; Xu B; Dalman RL
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.
    Petrinec D; Liao S; Holmes DR; Reilly JM; Parks WC; Thompson RW
    J Vasc Surg; 1996 Feb; 23(2):336-46. PubMed ID: 8637112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment With Small Molecule Inhibitors of Advanced Glycation End-Products Formation and Advanced Glycation End-Products-Mediated Collagen Cross-Linking Promotes Experimental Aortic Aneurysm Progression in Diabetic Mice.
    Li Y; Zheng X; Guo J; Samura M; Ge Y; Zhao S; Li G; Chen X; Shoji T; Ikezoe T; Miyata M; Xu B; Dalman RL
    J Am Heart Assoc; 2023 May; 12(10):e028081. PubMed ID: 37158066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.
    Curci JA; Petrinec D; Liao S; Golub LM; Thompson RW
    J Vasc Surg; 1998 Dec; 28(6):1082-93. PubMed ID: 9845660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation.
    Allaire E; Muscatelli-Groux B; Mandet C; Guinault AM; Bruneval P; Desgranges P; Clowes A; Méllière D; Becquemin JP
    J Vasc Surg; 2002 Nov; 36(5):1018-26. PubMed ID: 12422114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.
    Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J
    PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.
    Piechota-Polanczyk A; Demyanets S; Mittlboeck M; Hofmann M; Domenig CM; Neumayer C; Wojta J; Klinger M; Nanobachvili J; Huk I
    Eur J Vasc Endovasc Surg; 2015 May; 49(5):549-55. PubMed ID: 25800096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.
    Tarín C; Fernandez-Garcia CE; Burillo E; Pastor-Vargas C; Llamas-Granda P; Castejón B; Ramos-Mozo P; Torres-Fonseca MM; Berger T; Mak TW; Egido J; Blanco-Colio LM; Martín-Ventura JL
    Cardiovasc Res; 2016 Aug; 111(3):262-73. PubMed ID: 27229458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.
    Saratzis A; Kitas GD; Saratzis N; Melas N
    Angiology; 2010 Feb; 61(2):137-44. PubMed ID: 19625274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.